|
⚲
|
| Keyboard |
| Adelman Robert J
✚
|
|
|---|---|
| CIK # | 0001329161 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001329161] | |
| 4 | [0001329161] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Other | 461,687 | ||
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Buy | 416,666 | $12.00 | 4,999,992 |
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Conversion | 843,592 | ||
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Conversion | 214,692 | ||
|
Artiva Biotherapeutics Inc ARTV
Series A Convertible Preferred Stock · derivative
|
2024-07-22 | Conversion | 843,592 | ||
|
Artiva Biotherapeutics Inc ARTV
Series B Convertible Preferred Stock · derivative
|
2024-07-22 | Conversion | 214,692 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 3,786,957 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 1,123,862 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 247,343 | ||
|
RayzeBio Inc RYZB
Series A Convertible Preferred Stock · derivative
|
2023-09-19 | Conversion | 3,786,957 | ||
|
RayzeBio Inc RYZB
Series B Convertible Preferred Stock · derivative
|
2023-09-19 | Conversion | 1,123,862 | ||
|
RayzeBio Inc RYZB
Series C Convertible Preferred Stock · derivative
|
2023-09-19 | Conversion | 216,127 | ||
|
Ventyx Biosciences Inc VTYX
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 13,301 | $0.00 | |
|
Ventyx Biosciences Inc VTYX
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 13,301 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2022-05-25 | Sell | 702,737 | $4.12 | 2,895,276 |
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2022-05-16 | Sell | 95,800 | $10.45 | 1,001,110 |
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2022-05-13 | Sell | 35,850 | $10.45 | 374,632 |
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2022-05-12 | Sell | 124,525 | $10.39 | 1,293,815 |
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2022-05-11 | Sell | 17,700 | $10.38 | 183,726 |
|
Checkmate Pharmaceuticals Inc CMPI
Common Stock
|
2022-05-10 | Sell | 18,676 | $10.38 | 193,857 |
| showing 20 of 107 most recent transactions | |||||